{"id":14868,"date":"2012-05-15T03:30:00","date_gmt":"2012-05-15T01:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/fondi-clessidra-e-avista-in-rottapharm-mf\/"},"modified":"2012-05-15T03:30:00","modified_gmt":"2012-05-15T01:30:00","slug":"fondi-clessidra-e-avista-in-rottapharm-mf","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/fondi-clessidra-e-avista-in-rottapharm-mf\/","title":{"rendered":"Funds: Clessidra and Avista in Rottapharm (MF)"},"content":{"rendered":"<p style=\"line-height: normal; margin: 0cm 0cm 0pt; background: white; tab-stops: 45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt\" class=\"MsoNormal\"><span style=\"font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; color: black; font-size: 12pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: IT\">MILANO (MF-DJ)&#8211;Dopo mesi di stallo, Luigi Rovati [<em>nella foto a destra<\/em>]&nbsp;ha accelerato negli ultimi giorni la ricerca di un partner per la sua Rottapharm Madaus, la societa&#8217; farmaceutica di Monza fondata nel 1961 e poi integrata nel 2007 con la tedesca Madaus Pharma. Secondo quanto risulta a MF-Milano Finanza, il fondo Clessidra guidato da Claudio Sposito e il fondo americano Avista Capital Partners hanno raggiunto un&#8217;intesa di massima con Rovati, affiancato dall&#8217;advisor Credit Suisse, per acquistare il 25% ciascuno del capitale del gruppo sulla base di una valutazione del 100% di 1,7 miliardi di euro, quindi inferiore agli oltre 2 miliardi di cui si parlava a inizio anno e che avevano generato qualche perplessita&#8217; soprattutto tra le banche interpellate per organizzare il pacchetto di finanziamento dell&#8217;operazione. red\/lab <\/span><span style=\"font-family: &quot;Courier New&quot;; color: black; font-size: 12pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: IT\"><\/p>\n<p><\/span><\/p>\n<p style=\"line-height: normal; margin: 0cm 0cm 10pt; background: white; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto\" class=\"MsoNormal\"><span style=\"font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; color: black; font-size: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: IT; mso-ansi-language: EN-US\" lang=\"EN-US\">(END) Dow Jones Newswires<\/span><span style=\"font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; color: black; font-size: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: IT\"><\/p>\n<p><\/span><\/p>\n<p style=\"line-height: normal; margin: 0cm 0cm 10pt; background: white; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto\" class=\"MsoNormal\"><span style=\"font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; color: black; font-size: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: IT; mso-ansi-language: EN-US\" lang=\"EN-US\">May 15, 2012 03:08 ET (07:08 GMT)<\/p>\n<p><\/span><\/p>\n<p style=\"line-height: normal; margin: 0cm 0cm 0pt; text-autospace: ; mso-layout-grid-align: none\" class=\"MsoNormal\"><span style=\"font-family: BookAntiqua; color: #212120; mso-bidi-font-family: BookAntiqua; mso-ansi-language: EN-US\" lang=\"EN-US\"><\/p>\n<p><font size=\"3\" face=\"Calibri\">&nbsp;<img loading=\"lazy\" decoding=\"async\" style=\"width: 274px; height: 184px\" id=\"rg_hi\" class=\"rg_hi uh_hi\" alt=\"\" width=\"274\" height=\"184\" data-height=\"184\" data-width=\"274\" src=\"data:image\/jpeg;base64,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\n<\/p>\n","protected":false},"excerpt":{"rendered":"<p>MILANO (MF-DJ)&#8211;Dopo mesi di stallo, Luigi Rovati [nella foto a destra]&nbsp;ha accelerato negli ultimi giorni la ricerca di un partner per la sua Rottapharm Madaus, la societa&#8217; farmaceutica di Monza fondata nel 1961 e poi integrata nel 2007 con la tedesca Madaus Pharma. Secondo quanto risulta a MF-Milano Finanza, il fondo Clessidra guidato da Claudio &hellip;<\/p>\n","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-14868","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/14868","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=14868"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/14868\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=14868"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=14868"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=14868"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}